Agan, Pedro .

HRN: 24-66-35  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2024
CEFTRIAXONE 1G (VIAL)
03/02/2024
03/07/2024
IV
2g
OD
Pneumonia
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes